FY26 Results Presentation ASX Release 20th August 2026 ASX:TTX Tetratherix Limited 2026 Anchored by Science Tetratherix Limited (ASX:TTX) ( Tetratherix ) is pleased to announce its FY26 financial results presentation. A copy of the CEO letter contained in the Annual Report lodged with ASX...
Results Presentation 2026
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Story so far
Earlier from Tetratherix
- Appendix 4E and Annual Report 2026
- Successful Completion $15M Placement
- Precision medicine franchise launch and new revenue
- Tutelix Update
- Half Yearly Report and Accounts
Later from Tetratherix
- Application for quotation of securities - TTX
- Tetratherix Ships First US Polymer, Revenue Begins
- Line of sight ophthalmic tissue spacing US revenue
- Notification regarding unquoted securities - TTX
- Tegenix FDA Review Progress
Follow Tetratherix into a list and get an email when it puts out news.
Follow Tetratherix